Zolpidem
Back to searchMolecule Structure
Scientific Name
Zolpidem
Description of the Drug
Zolpidem is a sedative hypnotic used for the short-term treatment of insomnia to improve sleep latency.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00425
http://www.drugbank.ca/drugs/DB00425
Brand Name(s)
Not Available
Company Owner(s)
The Acme Laboratories Ltd, Sun Pharmaceutical Industries Inc, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Anchen Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Aytu Bioscience Inc, Torrent Pharmaceuticals Ltd, Chartwell Molecular Holdings Llc, Teva Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA A receptor alpha-1/beta-1/gamma-2 | PROTEIN COMPLEX | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2111392 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL80516 | |||||
| PharmGKB | PA451976 | |||||
| Human Metabolome Database | HMDB0005023 | |||||
| DrugBank | DB00425 | |||||
| PubChem: Thomson Pharma | 14874110 | |||||
| PubChem | 5732 | |||||
| LINCS | LSM-5560 | |||||
| Nikkaji | J33.161I | |||||
| PDBe | R5R | |||||
| BindingDB | 26266 | |||||
| EPA CompTox Dashboard | DTXSID7045946 | |||||
| DrugCentral | 2870 | |||||
| Brenda | 146004 | 145090 | ||||
| ChemicalBook | CB44188704 | CB82558860 | CB83360349 | CB84188702 | CB14188703 | |
| Guide to Pharmacology | 4362 | 4348 | ||||
| rxnorm | ZOLPIMIST | INTERMEZZO | EDLUAR | AMBIEN | ZOLPIDEM TARTRATE | ZOLPIDEM |
| KEGG Ligand | C07219 | |||||
| ChEBI | 10125 | |||||
| ZINC | ZINC000000003876 |
